Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,052 public trials 2,037 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00868413

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Site Reference ID/Investigator# 17841 La Jolla, California, United States

Site Reference ID/Investigator# 25899 Stanford, California, United States

Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States

Site Reference ID/Investigator# 21621 Columbus, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma

NCT01230983

Conditions: Cardiac Toxicity, Cardiotoxicity, Cardiovascular Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

NCT00010192

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00077467

Conditions: Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, Bone Marrow Diseases, +24 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

NCT00101270

Conditions: Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT00079404

Conditions: Acute Undifferentiated Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia

NCT00089349

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT00081133

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

NCT01301417

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +40 more
Locations: Southern Regional Medical Center Riverdale, Georgia, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions